Testing effectiveness (Phase 2)Study completedNCT04382040
What this trial is testing
A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19
Who this might be right for
COVID-19Corona Virus InfectionSARS-CoV 2+2 more
MGC Pharmaceuticals d.o.o 50